Cargando…

Evaluation of caspase 1 and sFas serum levels in patients with systemic sclerosis: correlation with lung dysfunction, joint and bone involvement.

Detalles Bibliográficos
Autores principales:	Dziankowska-Bartkowiak, Bozena, Waszczykowska, Elzbieta, Zalewska, Anna, Sysa-Jedrzejowska, Anna
Formato:	Texto
Lenguaje:	English
Publicado:	2003
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1781635/ https://www.ncbi.nlm.nih.gov/pubmed/14668093 http://dx.doi.org/10.1080/09629350310001633379

Ejemplares similares

Correlation of Endostatin and Tissue Inhibitor of Metalloproteinases 2 (TIMP2) Serum Levels With Cardiovascular Involvement in Systemic Sclerosis Patients
por: Dziankowska-Bartkowiak, Bożena, et al.
Publicado: (2005)

Dexamethasone effect on sFas/sFas ligand following cardiopulmonary bypass
por: Joashi, U, et al.
Publicado: (2001)

Angiogenin and SDF-1α serum concentration in patients with systemic sclerosis in relation to clinical status
por: Dziankowska-Bartkowiak, Bożena, et al.
Publicado: (2011)

Prevalence of ocular manifestations in systemic sclerosis patients
por: Waszczykowska, Arleta, et al.
Publicado: (2013)

Assessment of skin microcirculation by laser Doppler flowmetry in systemic sclerosis patients
por: Waszczykowska, Arleta, et al.
Publicado: (2014)

Chronic mucocutaneous candidiasis with endocrinopathy – case report
por: Lesiak, Aleksandra, et al.
Publicado: (2010)

Abnormalities of heart rate turbulence and heart rate variability as indicators of increased cardiovascular risk in patients with systemic sclerosis
por: Poliwczak, Adam R., et al.
Publicado: (2019)

The Imbalance Between Metalloproteinases and Their Tissue Inhibitors Is Involved in the Pathogenesis of Dermatitis Herpetiformis
por: Zebrowska, Agnieszka, et al.
Publicado: (2005)

Circulating angiostatin serum level in patients with systemic sclerosis
por: Gerlicz-Kowalczuk, Zofia, et al.
Publicado: (2017)

The Role of Angiogenesis Factors in the Formation of Vascular Changes in Scleroderma by Assessment of the Concentrations of VEGF and sVEGFR2 in Blood Serum and Tear Fluid
por: Waszczykowska, Arleta, et al.
Publicado: (2020)

ADAMTS13 deficiency and immunological abnormalities in patients with systemic sclerosis
por: Gerlicz-Kowalczuk, Zofia, et al.
Publicado: (2018)

Plasma Levels of sFas-sFasL and FASL Gene Expression Are Associated with Tuberculosis
por: Souza, Iury de Paula, et al.
Publicado: (2022)

Role and effectiveness of complex and supervised rehabilitation on overall and hand function in systemic sclerosis patients—one-year follow-up study
por: Waszczykowski, Michał, et al.
Publicado: (2021)

SAPO-1/Fas and sFas-L ratio, level of Bcl-2 and p53 as a predictors of multiple organ dysfunction syndrome in polytrauma
por: Kiseleva, A, et al.
Publicado: (2011)

FAS promoter polymorphisms and serum sFas level are associated with increased risk of nerve damage in Bangladeshi patients with Guillain-Barré syndrome
por: Islam, Zhahirul, et al.
Publicado: (2018)

Analysis of sFas IL-6 levels in thyroid-associated ophthalmopathy: Pre- or poststeroid pulse treatment
por: Maeda, Kimihito, et al.
Publicado: (2008)

Expression of Selected Integrins and Selectins in Bullous Pemphigoid
por: Żebrowska, Agnieszka, et al.
Publicado: (2007)

The Expression of Selected Proapoptotic Molecules in Dermatitis Herpetiformis
por: Agnieszka, Zebrowska, et al.
Publicado: (2012)

IL-17 Expression in Dermatitis Herpetiformis and Bullous Pemphigoid
por: Zebrowska, Agnieszka, et al.
Publicado: (2013)

Detection of sFas, sCD137, and IL-27 Cytokines as Potential Biomarkers for Hepatocellular Carcinoma Diagnosis
por: Do, Xuan-Hai, et al.
Publicado: (2023)

Serum concentrations of IL-17A, IL-17B, IL-17E and IL-17F in patients with systemic sclerosis
por: Robak, Ewa, et al.
Publicado: (2019)

Estimation of SLE activity based on the serum level of chosen cytokines and superoxide radical generation.
por: Waszczykowska, E, et al.
Publicado: (1999)

Evaluation of TGF-β1, CCL5/RANTES and sFas/Apo-1 urine concentration in children with ureteropelvic junction obstruction
por: Gawłowska-Marciniak, Aleksandra, et al.
Publicado: (2013)

IL-6, IL-10, sFas, granulysin and indicators of intestinal permeability as early biomarkers for a fatal outcome in COVID-19
por: Hernández-Solis, Alejandro, et al.
Publicado: (2022)

Atypical clinical presentation of lichen planus bullous in a systemic sclerosis patient
por: Gerlicz-Kowalczuk, Zofia A., et al.
Publicado: (2016)

Interleukin 6 and 8 Levels in Plasma and Fibroblast Cultures in Psoriasis
por: Zalewska, Anna, et al.
Publicado: (2006)

Circulating TCR gammadelta cells in the patients with systemic lupus erythematosus.
por: Robak, E, et al.
Publicado: (1999)

Behçet's disease leaves the silk road
por: Woźniacka, Anna, et al.
Publicado: (2014)

The use of isotretinoin in low doses and unconventional treatment regimens in different types of acne: a literature review
por: Torzecka, Jolanta D., et al.
Publicado: (2017)

Serum Apoptosis Markers Related to Liver Damage in Chronic Hepatitis C: sFas as a Marker of Advanced Fibrosis in Children and Adults While M30 of Severe Steatosis Only in Children
por: Valva, Pamela, et al.
Publicado: (2013)

Quality of life and satisfaction with life in SLE patients—the importance of clinical manifestations
por: Kulczycka, Lilianna, et al.
Publicado: (2010)

Topical steroid therapy in atopic dermatitis in theory and practice
por: Jeziorkowska, Renata, et al.
Publicado: (2015)

SFAs do not impair endothelial function and arterial stiffness(1)(2)(3)
por: Sanders, Thomas AB, et al.
Publicado: (2013)

Medium dose ultraviolet A1 phototherapy and mRNA expression of interleukin 8, interferon γ, and chemokine receptor 4 in acute skin lesions in atopic dermatitis
por: Bogaczewicz, Jarosław, et al.
Publicado: (2016)

Antinuclear antibodies in rosacea patients
por: Woźniacka, Anna, et al.
Publicado: (2013)

Fas–Fas Ligand: Checkpoint of T Cell Functions in Multiple Sclerosis
por: Volpe, Elisabetta, et al.
Publicado: (2016)

Procedimiento para la conversión de estados financieros según SFAS-52 del AICPA
por: Luis Hernández, Jorge Alberto
Publicado: (1998)

F241. DEVELOPMENT AND VALIDATION OF THE SOCIAL FUNCTIONING ASSESSMENT SCALE (SFAS) FOR PEOPLE WITH SCHIZOPHRENIA IN TURKEY
por: Yildiz, Mustafa, et al.
Publicado: (2018)

Morbus Behçet – a rare disease in Central Europe
por: Woźniacka, Anna, et al.
Publicado: (2015)

Cellulite: a cosmetic or systemic issue? Contemporary views on the etiopathogenesis of cellulite
por: Tokarska, Kamila, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_fk3uf1f0sa5kao3m521jcjkp9r